Evaluation | Observer 1 | Observer 2 | ||
---|---|---|---|---|
volume (cm3) | Δvolume(%) | volume (cm3) | Δvolume(%) | |
Local complete response (n:31) | ||||
(a) MRI before treatment | 33 (13–104) | - | 33 (11–130) | - |
(b) MRI at the first BCT* | 8.5 (0.4–28) | 73 % (48–97) | 8 (1–23) | 73 % (37–95) |
(c) MRI at the final BCT* | 3.7 (0–14) | 88 % (75–100) | 3.3 (0.5–9) | 89 % (80–100) |
Local residual tumor (n:4) | ||||
(a) MRI before treatment | 32 (15–44) | - | 28 (19–37) | - |
(b) MRI at the first BCT | 18 (14–23) | 36 % (8–55) | 16 (10–23) | 39 % (21–68) |
(c) MRI at the final BCT | 13 (4–15) | 53 % (21–67) | 11 (3–13) | 55 % (28–74) |